Device Trial Radar · NCT03320473
IOL Implantation After KAMRA Inlay Removal
Last checked: Nov 19, 2026Latest source record: May 10, 2023 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
29
Actual
Start
Dec 5, 2017
Primary completion
Jun 20, 2022
Study completion Jun 20, 2022
Sponsor
- Lead sponsor
- AcuFocus, Inc.Not on our public-company list
- Sponsor type
- Industry
- First posted
- Oct 25, 2017
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated device
- No
- Who can join
- All sexes, from 45 years
- Healthy volunteers
- Yes
Summary
As written by the sponsor on the registry.
A. The primary purpose of the study is to evaluate outcomes of aphakic eyes implanted with the IC-8 IOL following cataract removal in prior inlay patients after KAMRA inlay removal. B. The secondary purpose of the study is to determine whether there are any changes in biometry measurements before and after the inlay removal and how the changes affect the calculated IOL power.
Conditions
- Cataract
- Presbyopia
Interventions
IC-8 IOLDevice
The AcuFocus IC-8 intraocular lens (IC-8 IOL) is a one-piece hydrophobic acrylic posterior chamber IOL into which a circular mask with a small 1.36 mm central aperture has been embedded. The IOL mask works by extending the depth of focus and its design is based on the KAMRA corneal inlay, which operates under the principle of small aperture optics.
Primary outcomes
What the sponsor says the trial is designed to measure.
- BCDVATime frame: 3 months
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Asian Eye Institute
Makati City, Philippines
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.